PUBLISHER: BCC Research | PRODUCT CODE: 1292414
PUBLISHER: BCC Research | PRODUCT CODE: 1292414
The global market for hematology analyzers is estimated to increase from $4.0 billion in 2023 to reach $5.3 billion by 2028, at a compound annual growth rate (CAGR) of 5.7% from 2023 through 2028.
The global market for hematology analyzers for reagents and consumables segment is estimated to increase from $2.7 billion in 2023 to reach $3.6 billion by 2028, at a CAGR of 6.0% from 2023 through 2028.
The global market for hematology analyzers for instruments is estimated to increase from $1.0 billion in 2023 to reach $1.3 billion by 2028, at a CAGR of 4.8% from 2023 through 2028.
The current report provides detailed exposure to the hematology analyzer market. This report highlights the current and future market potential of hematology analyzers, along with a detailed analysis of the drivers and challenges in the market. The report also covers market projections through 2028 and market rank for key players. It covers the competitive environment, regulatory scenario and outlines market share based on product/service and end user. Products/services include Instruments, Reagents and Consumables and Services. The market end users are hospitals and clinics, diagnostic centers, research institutes and other end users. This report includes company profiles of key players with detailed information on business segments, financials, product portfolios and recent developments. The report examines the impact of the COVID-19 pandemic on this market.
By geographical region, the market is segmented into North America, Europe, Asia-Pacific and the Rest of the World. The North American region includes the U.S. and Canada; Europe includes Germany, the UK, Italy, France, and the Rest of Europe; Asia-Pacific includes China, India, Japan and the Rest of Asia-Pacific. For market estimates, data has been provided for 2020 and 2021 as historical years, 2022 as the base year and forecasts have been made through 2028.